Clinical trial
Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure…
NCT00228514 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00228514 |
|---|---|
| Title | Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study |
| Official title | Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) PET Sub Study |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rosuvastatin, Heart Failure, Positron Emission Tomography (PET) |
| Intervention type | Drug, Procedure |
| Interventions | Rosuvastatin, Positron emission tomography |
| Enrollment | 40 |
| Start date | Feb 1, 2004 |
| Completion | Jul 1, 2007 |
| First posted | Sep 29, 2005 |
| Last update posted | Nov 15, 2010 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: